Cargando…

Blood transcriptional signatures for tuberculosis testing

Detalles Bibliográficos
Autores principales:	Mendelsohn, Simon C, Mbandi, Stanley Kimbung, Hatherill, Mark, Scriba, Thomas J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919958/ https://www.ncbi.nlm.nih.gov/pubmed/32178777 http://dx.doi.org/10.1016/S2213-2600(20)30045-X

Ejemplares similares

Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol
por: Mulenga, Humphrey, et al.
Publicado: (2019)

Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis
por: Mulenga, Humphrey, et al.
Publicado: (2020)

The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Clinical predictors of pulmonary tuberculosis among South African adults with HIV
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Systematic review of diagnostic and prognostic host blood transcriptomic signatures of tuberculosis disease in people living with HIV
por: Mendelsohn, Simon C, et al.
Publicado: (2023)

Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Plasma Type I IFN Protein Concentrations in Human Tuberculosis
por: Llibre, Alba, et al.
Publicado: (2019)

Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis
por: Mulenga, Humphrey, et al.
Publicado: (2021)

The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study
por: Sumner, Tom, et al.
Publicado: (2021)

Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy
por: Sumner, Tom, et al.
Publicado: (2019)

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
por: Darboe, Fatoumatta, et al.
Publicado: (2019)

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2022)

Headway made towards biosignatures for incipient tuberculosis
por: Scriba, Thomas J, et al.
Publicado: (2020)

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
por: Scriba, Thomas J, et al.
Publicado: (2021)

Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
por: Baguma, Richard, et al.
Publicado: (2021)

Regional changes in tuberculosis disease burden among adolescents in South Africa (2005–2015)
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2020)

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
por: Penn-Nicholson, Adam, et al.
Publicado: (2020)

Inferring bona fide transfrags in RNA-Seq derived-transcriptome assemblies of non-model organisms
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2015)

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
por: Müller, Julius, et al.
Publicado: (2019)

A glance at quality score: implication for de novo transcriptome reconstruction of Illumina reads
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2014)

Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
por: Bender Ignacio, Rachel A., et al.
Publicado: (2022)

A prospective blood RNA signature for tuberculosis disease risk
por: Zak, Daniel E., et al.
Publicado: (2016)

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
por: Llibre, Alba, et al.
Publicado: (2022)

A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates
por: Rodo, Miguel J., et al.
Publicado: (2019)

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
por: Petruccioli, Elisa, et al.
Publicado: (2016)

The blood transcriptional signature for active and latent tuberculosis
por: Deng, Min, et al.
Publicado: (2019)

Host blood RNA signatures predict the outcome of tuberculosis treatment
por: Thompson, Ethan G., et al.
Publicado: (2017)

Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection
por: Mpande, Cheleka A.M., et al.
Publicado: (2021)

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
por: Baguma, Richard, et al.
Publicado: (2017)

An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis
por: Berry, Matthew P. R., et al.
Publicado: (2010)

Functional, Antigen-Specific Stem Cell Memory (T(SCM)) CD4(+) T Cells Are Induced by Human Mycobacterium tuberculosis Infection
por: Mpande, Cheleka A. M., et al.
Publicado: (2018)

Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention
por: Fiore-Gartland, Andrew, et al.
Publicado: (2018)

Multidimensional analysis of immune responses identified biomarkers of recent Mycobacterium tuberculosis infection
por: Lloyd, Tessa, et al.
Publicado: (2021)

The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis
por: Blankley, Simon, et al.
Publicado: (2014)

Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production
por: Thirunavukkarasu, Shyamala, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_slm3fec4bij5ubgdsg7k3cenm1